急诊科头盔式CPAP:叙述性综述
本叙述性综述介绍头盔式持续气道正压(CPAP)的技术特点与临床适应证,并探讨其在急诊科应用的优势与挑战。头盔CPAP通过维持整个呼吸周期的气道正压(PEEP)改善氧合,较其他无创通气接口耐受性更好、密封性好且气道稳定性佳;新冠疫情期间有证据显示其可降低气溶胶播散风险。在急性心源性肺水肿、Covid-19肺炎、免疫功能低下患者、急性胸部创伤及姑息治疗患者中显示出潜在临床获益,与常规氧疗相比可降低插管率和死亡率。结论认为头盔CPAP是急诊急性呼吸衰竭患者可选的无创通气接口之一,更适合长时间使用。
要点
- 头盔CPAP通过在整个呼吸周期维持PEEP保持气道开放来改善氧合,是急诊急性呼吸衰竭患者的无创通气接口之一。
- 与常规氧疗相比,头盔CPAP已显示可降低插管率和死亡率。
- 头盔CPAP较其他无创通气接口耐受性更好,密封性好且气道稳定性佳,更适合长时间使用。
- 新冠疫情期间有证据显示头盔CPAP可降低气溶胶播散风险。
- 头盔CPAP的潜在临床获益见于急性心源性肺水肿、Covid-19肺炎、免疫功能低下患者、急性胸部创伤及姑息治疗患者。
适用人群与场景
- 急诊科就诊的急性呼吸衰竭患者
- 急性心源性肺水肿患者
- Covid-19肺炎患者
- 免疫功能低下患者
- 急性胸部创伤患者
- 姑息治疗患者
研究设计与关键结果
- 叙述性综述,描述头盔CPAP的技术特点与临床适应证,并探讨其在急诊科应用的优势与挑战。
- 头盔CPAP较其他无创通气接口耐受性更好,密封性好且气道稳定性佳。
- 新冠疫情期间有证据显示头盔CPAP可降低气溶胶播散风险。
- 与常规氧疗相比,头盔CPAP已显示可降低插管率和死亡率。
- 头盔CPAP在急性心源性肺水肿、Covid-19肺炎、免疫功能低下患者、急性胸部创伤及姑息治疗患者中显示出潜在临床获益。
证据类型、等级与局限
- 证据类型:叙述性综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 头盔CPAP可作为急诊急性呼吸衰竭患者的无创通气接口之一,较其他接口耐受性更好,适合长时间使用。
- 在急性心源性肺水肿、Covid-19肺炎、免疫功能低下患者、急性胸部创伤及姑息治疗患者中可考虑使用头盔CPAP。
- 在感染性疾病患者中使用头盔CPAP可能降低气溶胶播散风险。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The choice of correct interface for the right patient is crucial for the success of non-invasive ventilation (NIV) therapy. Helmet CPAP is a type of interface used to deliver NIV. Helmet CPAP improves oxygenation by keeping the airway open throughout the breathing cycle with positive end-expiratory pressure (PEEP).
OBJECTIVE: This narrative review describes the technical aspects and clinical indications of helmet continuous positive airway pressure (CPAP). In addition, we explore the advantages and challenges faced using this device at the Emergency Department (ED).
DISCUSSION: Helmet CPAP is tolerable than other NIV interfaces, provides a good seal and has good airway stability. During Covid-19 pandemic, there are evidences it reduced the risk of aerosolization. The potential clinical benefit of helmet CPAP is demonstrated in acute cardiogenic pulmonary oedema (ACPO), Covid-19 pneumonia, immunocompromised patient, acute chest trauma and palliative patient. Compare to conventional oxygen therapy, helmet CPAP had been shown to reduce intubation rate and decrease mortality.
CONCLUSION: Helmet CPAP is one of the potential NIV interface in patients with acute respiratory failure presenting to the emergency department. It is better tolerated for prolonged usage, reduced intubation rate, improved respiratory parameters, and offers protection against aerosolization in infectious diseases.
参考来源
- Adi O, Fong CP, Keong YY, et al. Helmet CPAP in the emergency department: A narrative review. Am J Emerg Med. 2023. PMID: 36870251. doi:10.1016/j.ajem.2023.02.030
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。